Surgical management of carcinomatosis from colorectal cancer

Clinics in Colon and Rectal Surgery

Volumn 18, Issue 3, 2005, Pages 190-203

  Sugarbaker, Paul H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

5 fluorouracil; Colorectal cancer; Hyperthermia; Intraperitoneal chemotherapy; Mitomycin C; Peritoneal surface malignancy; Peritonectomy

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; OXALIPLATIN; PACLITAXEL;

CANCER CHEMOTHERAPY; CARCINOMATOSIS; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG DELIVERY SYSTEM; DRUG TOLERABILITY; FATALITY; HUMAN; HYPERTHERMIC THERAPY; INTRAOPERATIVE PERIOD; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PERITONECTOMY; PERITONEUM CANCER; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 24344490757     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916280     Document Type: Review

References (48)

1. Temple WJ, ed. Surgical Techniques and Outcomes. Surgical Oncology Clinics of North America. Philadelphia: WB Saunders; 2002
2. Taylor I. What constitutes good practice in surgical oncology? Eur J Surg Oncol 2001;27:517-520
3. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995; 221:29-42
4. Spratt JS, Adcock RA, Sherrill W, Tavathen S. Hyperthermia peritoneal perfusion system in canines. Cancer Res 1980;40: 253-255
5. Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW, Myers CE. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. Cancer Res 1981;41:1916-1922
6. Koga S, Hamazoe R, Maeta M, Shimizu N, Kanayama H, Osaki Y. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 1984;44:1840-1842
7. Flessner MF, Dedrick RL, Schultz JS. A distributable model of peritoneal plasma transport: theoretical considerations. Am J Physiol 1984;246:R597-R607
8. Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Myers CE. Prospective randomized trial of intravenous vs. peritoneal 5-FU in patients with advanced primary colon or rectal cancer. Semin Oncol 1985;12(3 suppl 4):101-111
9. Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232-237
10. Fujimoto S, Shrestha RD, Kokubun M, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36-41
11. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-132
12. Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437-444
13. Yu W, Whang I, Suh I, Averbach A, Chang D, Sugarbaker PH. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg 1998;228:347-354
14. Moran BJ, Cecil TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003;12:585-603
15. Urano M, Kuroda M, Nishimura Y. For the clinical application of thermo-chemotherapy given at mild temperatures. Int J Hyperthermia 1999;15:79-107
16. Verwaal V, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743
17. Gertsch P. A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments. Surg Oncol Clin N Am 2003;12:531-541
18. Sugarbaker PH, Graves T, DeBruijn EA, et al. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790-5794
19. Jacquet P, Averbach A, Stephens AD, et al. Heated intraoperative intraperitoneal mitomycin C and early post-operative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology 1998;55:130-138
20. Chu DZJ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in non-gynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63:364-367
21. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies. Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363
22. Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002;89: 1545-1550
23. Jones T. I want to live!. In: Erdrich L, Kenison K, eds. The Best American Short Stories 1993. New York: Houghton Mifflin; 1993:127-145
24. Sampson JA. Implantation peritoneal carcinomatosis of ovarian origin. Am J Pathol 1931;7:423-443
25. Weiss L. Metastatic inefficiency: causes and consequences. Cancer Rev 1986;3:1-24
26. Spratt JS, Edward M, Kubota T, Lindberg R, Tseng MT. Peritoneal carcinomatosis: anatomy, physiology, diagnosis, management. Curr Probl Cancer 1986;10:555-585
27. Zoetmulder FAN. Modelstudies over het Colorectale Carcinoom. Amsterdam: Rodopi; 1982
28. Autio V. The spread of intraperitoneal infection. Studies with Roentgen contrast medium. Acto Chir Scand 1964;36(suppl 321):5-31
29. Meyers MA. Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 1973;119:198-206
30. Shimotsuma M, Shields JW, Simpson-Morgan MW, et al. Morpho-physiological function and role of omental milky spots as omentum associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology 1993;26:90-101
31. Sugarbaker PH. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In: Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Boston: Kluwer, 1996:79-100
32. Carmignani CP, Sugarbaker T, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 2003;22:465-472
33. Archer AG, Sugarbaker PH, Jelinek JS. Radiology of peritoneal carcinomatosis. In: Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Boston: Kluwer, 1996:263-288
34. Jacquet P, Jelinek JS, Chang D, Koslowe P, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 1995;181:530-538
35. Portilla AG, Sugarbaker PH, Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic factors. World J Surg 1999;23:23-29
36. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43(suppl):S15-S25
37. Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum 2000; 43:1341-1346
38. Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-76
39. Witkamp AJ, de Bree E, Kaag MM, et al. Extensive cytoreductive surgery followed by infra-operative hyperthermia intraperitoneal chemotherapy with mitomycin C in patients with carcinomatosis of colorectal cancer. Eur J Surg 2001;37:979-984
40. Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003;138:26-33
41. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol 2003;21:799-806
42. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2003;21:3737-3743
43. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004;22:3284-3292
44. Sugarbaker PH, Jablonski KA. Prognostic factors of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995;221:124-132
45. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999;6: 790-796
46. Gonzalez-Bayon L, Sugarbaker PH, Gonzalez-Moreno S, de Lima Vazquez V, Alves S, Moran BJ. Initiation of a program in peritoneal surface malignancy. Surg Oncol Clin N Am 2003;12:741-753
47. McQuellon RP, Loggie BW, Fleming RA, et al. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001;27: 65-73
48. Sugarbaker PH. Carcinomatosis, is cure an option? J Clin Oncol 2003;21:762-764